ERIKA DICK: Open Payments
NPI 1245685403 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 41 payments from 15 companies in 2025. Trend: 2023 $155 · 2024 $433 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $245 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| ABBVIE INC. | 4 | $72 |
| Amgen Inc. | 4 | $68 |
| SHIELD THERAPEUTICS INC | 1 | $49 |
| PFIZER INC. | 3 | $49 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Lundbeck LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Seqirus USA Inc | 1 | $16 |
Products named: FARXIGA, XIFAXAN, REXULTI, ACCRUFER, ELIQUIS, BREZTRI, VRAYLAR, OTEZLA.
Industry payments across KS — which companies pay providers there.
